SCHEMBL26794271

SCHEMBL26794271

CN1c2ccccc2C(C)(O)c2cc3c(cc21)C(C)(C)c1ccccc1-3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.37
HTT P42858 8/20 0.36
LMNA P02545 5/20 0.36
KMT2A Q03164 11/20 0.35
MEN1 O00255 10/20 0.35
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 4/20 0.35
TSHR P16473 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
CASP1 P29466 1/20 0.35
HSD17B10 Q99714 1/20 0.35
THRB P10828 5/20 0.34
RECQL P46063 5/20 0.34
POLB P06746 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
MAPK1 P28482 2/20 0.34
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12793261 0.88 HTT (0.43) MAPTHTTLMNAKMT2AMEN1
SCHEMBL12776550 0.82 HTT (0.43) MAPTHTTLMNAKMT2AMEN1
SCHEMBL12776568 0.79 HTT (0.38) MAPTHTTLMNAKMT2AMEN1
SCHEMBL21377074 0.79 HTT (0.36) MAPTHTTLMNAKMT2AMEN1
SCHEMBL21376888 0.79 HTT (0.38) MAPTHTTLMNAKMT2AMEN1
SCHEMBL21377087 0.79 HTT (0.38) MAPTHTTLMNAKMT2AMEN1
SCHEMBL21376885 0.78 HTT (0.39) MAPTHTTLMNAKMT2AMEN1
SCHEMBL12776556 0.78 HTT (0.39) MAPTHTTLMNAKMT2AMEN1
SCHEMBL12723265 0.76 HTT (0.51) MAPTHTTLMNAKMT2AMEN1
SCHEMBL5014621 0.76 HTR2A (0.43) MAPTLMNAKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230380274-A1 ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230380274-A1 ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME TEAD2, TEAD3, TEAD4 MAPT 756/4885HTT 1968/4885LMNA 2894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.